Search results
What to Know About Steroids for Treating Back Pain
Healthline· 5 days agoSteroids help reduce inflammation that can cause severe back pain, but steroids aren’t long-term solutions. Back pain can limit your mobility and...
New Drugs Won’t Help If They Can’t Reach Patients. My Family Learned the Hard Way.
Barrons.com· 22 hours agoChristine Schuster spent her life in healthcare. That wasn’t enough when her husband couldn’t get...
Amy Schumer says she feels 'a lot better' amid treatment for Cushing syndrome. Here's what to know...
Yahoo Life· 5 days agoIt occurs when the body produces an excess amount of cortisol, known as the "stress hormone," over a...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters via Yahoo Finance· 7 days agoCencora beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly specialty medicines that treat complex diseases such as cancer ...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 1 day agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters· 7 days ago, opens new tab beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly specialty medicines that treat complex diseases such ...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 1 day agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters via AOL· 5 days ago(Reuters) -Amgen on Thursday said it was very encouraged after completing an interim analysis of its...
Altamira Therapeutics files new RNA delivery patent By Investing.com
Investing.com· 7 days agoAltamira Therapeutics Ltd. (NASDAQ:CYTO), a biopharmaceutical company focusing on RNA delivery...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 6 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...